New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 1, 2013
10:01 EDTARP, ZTS, SPN, PDS, OII, NCS, NILE, SSH, PTEN, NOV, HP, SFLY, OIS, NBR, EWOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Blue Nile (NILE) initiated with an Outperform at Wells Fargo... Edwards Lifesciences (EW) initiated with a Buy at Janney Capital... Helmerich & Payne (HP) initiated with a Neutral at Credit Suisse... NCI Building Systems (NCS) initiated with a Buy at BB&T... Nabors Industries (NBR) initiated with an Underperform at Credit Suisse... National Oilwell (NOV) initiated with a Neutral at Credit Suisse... Oceaneering (OII) initiated with a Neutral at Credit Suisse... Oil States (OIS) initiated with an Outperform at Credit Suisse... Patterson-UTI Energy (PTEN) initiated with a Neutral at Credit Suisse... Precision Drilling (PDS) initiated with a Neutral at Credit Suisse... Shutterfly (SFLY) initiated with a Market Perform at Wells Fargo... Sunshine Heart (SSH) initiated with an Overweight at Piper Jaffray... Zoetis (ZTS) initiated with a Buy at ISI Group... Superior Energy (SPN) initiated with an Outperform at Credit Suisse... Atlas Resource Partners (ARP) initiated with a Neutral at Citigroup.
News For NILE;EW;HP;NCS;NBR;NOV;OII;OIS;PTEN;PDS;SFLY;SSH;SPN;ZTS;ARP From The Last 14 Days
Check below for free stories on NILE;EW;HP;NCS;NBR;NOV;OII;OIS;PTEN;PDS;SFLY;SSH;SPN;ZTS;ARP the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
April 14, 2014
10:25 EDTEWEdwards Lifesciences rises sharply following court action, upgrades
Subscribe for More Information
10:00 EDTEWEdwards Lifesciences rises 13.9%
Subscribe for More Information
09:00 EDTEWEdwards Lifesciences rises 11.3%
Edwards Lifesciences is up 11.3%, or $8.28, to $81.25
08:59 EDTEWOn The Fly: Pre-market Movers
Subscribe for More Information
08:12 EDTEWEdwards Lifesciences price target raised to $90-$91 from $82-$83 at Wells Fargo
Wells Fargo increased its price target on Edwards after a federal court granted a preliminary injunction limiting the sale of a competing product, Medtronic's (MDT) CoreValve. The firm said the injunction was a "major surprise," and estimates that the injunction could increase Edwards EPS by 15c in 2014 and 34c in 2015. Wells keeps an Outperform rating on the stock.
07:39 EDTEWEdwards Lifesciences upgraded to Buy from Fair Value at CRT Capital
Subscribe for More Information
07:03 EDTNBRNabors Industries to separate roles of Chairman of the Board and CEO
Subscribe for More Information
06:22 EDTEWMedtronic downgraded to Neutral from Overweight at JPMorgan
Subscribe for More Information
06:21 EDTEWEdwards Lifesciences upgraded to Neutral from Underweight at JPMorgan
Subscribe for More Information
April 13, 2014
15:10 EDTEWMedtronic says CoreValve ruling has no impact outside U.S.
Subscribe for More Information
April 12, 2014
19:50 EDTEWEdwards says court limits sale of Medtronic CoreValve system in U.S.
Edwards Lifesciences (EW) announced that the U.S. District Court for the District of Delaware granted a preliminary injunction limiting the sale of Medtronic's (MDT) CoreValve system in the United States. The court ordered the injunction to go into effect in seven business days. The hearing related to a federal jury decision in 2010 that CoreValve willfully infringes Edwards' U.S. Andersen transcatheter aortic valve replacement patent. At the conclusion of the hearing, Chief Judge Gregory Sleet ordered Edwards and Medtronic to confer on what instances the CoreValve device could continue to be used in the treatment of U.S. patients at centers currently trained on CoreValve. There is a large body of evidence demonstrating the safety and performance of the Edwards SAPIEN valves, and the company remains committed to ensuring patients have appropriate access to transcatheter therapy. This case was initiated by Edwards in 2008. On April 1, 2010, a federal jury found Medtronic willfully infringed Edwards' U.S. Andersen patent and awarded damages. In Nov. 2012, the U.S. Court of Appeals for the Federal Circuit affirmed the jury decision; in Oct. 2013, the U.S. Supreme Court declined to hear Medtronic's appeal. The patent involved in this suit is part of the Andersen family of patents. The U.S. Andersen patent was issued in 1995. A petition has been filed with the U.S. Patent and Trademark Office to extend this patent into early 2016. In a separate case, a federal jury in January found that Medtronic CoreValve had willfully infringed Edwards' U.S. Cribier transcatheter heart valve patent, and awarded damages to Edwards in that trial.
April 11, 2014
12:42 EDTSFLYOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
10:35 EDTNBRHigh option volume stocks: HZNP NI IPG CYTR SNV NBR
Subscribe for More Information
09:00 EDTSFLYShutterfly rises 3.2%
Subscribe for More Information
06:20 EDTSFLYShutterfly upgraded to Buy from Neutral at Goldman
Subscribe for More Information
April 10, 2014
07:24 EDTSSHInternational Society for Heart & Lung Transplantation to hold annual meeting
Subscribe for More Information
April 9, 2014
11:13 EDTSSHSunshine Heart management to meet with Oppenheimer
Subscribe for More Information
10:18 EDTNOVNational Oilwell sees NOW spinoff completed in Q2
National Oilwell Varco announced that Marcela E. Donadio has been appointed to the National Oilwell Varco Board of Directors effective April 8. NOV also announced that NOW Inc. has filed its amended Form 10 with the Securities and Exchange Commission. The company anticipates the spin will be completed in 2Q14.
April 8, 2014
16:48 EDTSFLYPoint72 Asset reports 5.4% passive stake in Shutterfly
07:26 EDTEWElsevier Business Intelligence to hold a conference
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use